Viva Biotech Holdings (VB0) — Working Capital to Net Assets Ratio
Viva Biotech Holdings (VB0) has a Working Capital to Net Assets ratio of 19.3% as of June 2025. Working capital of €754.42 Million (current assets of €1.75 Billion minus current liabilities of €991.68 Million) is measured against net assets of €3.91 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See VB0 net asset quality score to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Viva Biotech Holdings Working Capital to Net Assets (2016–2024)
This chart shows how Viva Biotech Holdings's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2016 to 2024. As of June 2025, the ratio stands at 19.3%, reflecting working capital of €754.42 Million against net assets of €3.91 Billion EUR. Check tangible equity quality of Viva Biotech Holdings to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Viva Biotech Holdings (2016–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Viva Biotech Holdings from 2016 to 2024, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Viva Biotech Holdings (VB0) market capitalisation.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 19.7% | €749.94 Million | €3.82 Billion | €1.88 Billion | €1.13 Billion | ▲ +6.2 pp |
| 2023 | 13.5% | €496.74 Million | €3.69 Billion | €2.03 Billion | €1.53 Billion | ▲ +33.8 pp |
| 2022 | -20.4% | €-733.75 Million | €3.60 Billion | €1.94 Billion | €2.67 Billion | ▼ -47.4 pp |
| 2021 | 27.0% | €1.06 Billion | €3.91 Billion | €1.98 Billion | €926.60 Million | ▼ -42.6 pp |
| 2020 | 69.6% | €2.62 Billion | €3.76 Billion | €3.35 Billion | €735.67 Million | ▲ +12.2 pp |
| 2019 | 57.5% | €1.02 Billion | €1.78 Billion | €1.09 Billion | €72.96 Million | ▼ -21.6 pp |
| 2018 | 79.0% | €198.71 Million | €251.44 Million | €241.17 Million | €42.46 Million | ▲ +48.6 pp |
| 2017 | 30.4% | €46.46 Million | €152.76 Million | €83.45 Million | €36.99 Million | ▼ -33.4 pp |
| 2016 | 63.8% | €48.84 Million | €76.50 Million | €65.16 Million | €16.32 Million | — |